Oksana Goroshchuk

Artiklar

Article: THE FASEB JOURNAL. 2021;35(7):e21741
Thermal proteome profiling identifies PIP4K2A and ZADH2 as off-targets of Polo-like kinase 1 inhibitor volasertib
Goroshchuk O; Kolosenko I; Kunold E; Vidarsdottir L; Pirmoradian M; Azimi A; Jafari R; Palm-Apergi C
Article: THE FASEB JOURNAL. 2021;35(5):e21476
RNAi prodrugs decrease elevated mRNA levels of Polo-like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patients
Kolosenko I; Goroshchuk O; Vidarsdottir L; Bjorklund A-C; Dowdy SF; Palm-Apergi C
Article: SCIENTIFIC REPORTS. 2020;10(1):2688
Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patients
Goroshchuk O; Vidarsdottir L; Bjorklund A-C; Hamil AS; Kolosenko I; Dowdy SF; Palm-Apergi C
Article: METHODS IN MOLECULAR BIOLOGY. 2019;2036:53-72
Designing siRNA and Evaluating Its Effect on RNA Targets Using qPCR and Western Blot.
Vidarsdottir L; Goroshchuk O; Kolosenko I; Palm-Apergi C
Article: JOURNAL OF CONTROLLED RELEASE. 2017;261:199-206
RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients
Kolosenko I; Edsbacker E; Bjorklund A-C; Hamil AS; Goroshchuk O; Grander D; Dowdy SF; Palm-Apergi C

Thesis / dissertation: 2020
Targeting polo-like kinase 1 in pediatric leukemia
Goroshchuk, Oksana
Review: ONCOGENE. 2019;38(1):1-16
Polo-like kinases and acute leukemia
Goroshchuk O; Kolosenko I; Vidarsdottir L; Azimi A; Palm-Apergi C

Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2020